Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer
- 31 March 2011
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 17 (7), 1850-1857
- https://doi.org/10.1158/1078-0432.ccr-10-2180
Abstract
Purpose: Despite continual efforts to develop a prognostic model of gastric cancer by using clinical and pathologic parameters, a clinical test that can discriminate patients with good outcomes from those with poor outcomes after gastric cancer surgery has not been established. We aim to develop practical biomarker-based risk score that can predict relapse of gastric cancer after surgical treatment. Experimental Design: Microarray technologies were used to generate and analyze gene expression profiling data from 65 gastric cancer patients to identify biomarker genes associated with relapse. The association of expression patterns of identified genes with relapse and overall survival was validated in independent gastric cancer patients. Results: We uncovered two subgroups of gastric cancer that were strongly associated with the prognosis. For the easy translation of our findings into practice, we developed a scoring system based on the expression of six genes that predicted the likelihood of relapse after curative resection. In multivariate analysis, the risk score was an independent predictor of relapse in a cohort of 96 patients. We were able to validate the robustness of the six-gene signature in an additional independent cohort. Conclusions: The risk score derived from the six-gene set successfully prognosticated the relapse of gastric cancer patients after gastrectomy. Clin Cancer Res; 17(7); 1850–7. ©2011 AACR.Keywords
Other Versions
This publication has 31 references indexed in Scilit:
- Technology Insight: tuning into the genetic orchestra using microarrays—limitations of DNA microarrays in clinical practiceNature Clinical Practice Oncology, 2006
- Molecular Dissection of 17q12 Amplicon in Upper Gastrointestinal AdenocarcinomasMolecular Cancer Research, 2006
- Perspectives in the treatment of gastric cancerNature Clinical Practice Oncology, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerThe New England Journal of Medicine, 2004
- Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genesInternational Journal of Cancer, 2004
- Genomic profiling of gastric cancer predicts lymph node status and survivalOncogene, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerThe New England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancerSurgical Oncology, 1992